Childhood Arthritis and Rheumatology Research Alliance Consensus Clinical Treatment Plans for Juvenile Dermatomyositis with Persistent Skin Rash.

Citation data:

The Journal of rheumatology, ISSN: 0315-162X, Vol: 44, Issue: 1, Page: 110-116

Publication Year:
2017
Usage 47
Abstract Views 42
Link-outs 5
Captures 24
Readers 22
Exports-Saves 2
Social Media 1
Shares, Likes & Comments 1
Citations 1
Citation Indexes 1
PMID:
27803135
DOI:
10.3899/jrheum.160688
Author(s):
Huber, Adam M, Kim, Susan, Reed, Ann M, Carrasco, Ruy, Feldman, Brian M, Hong, Sandy D, Kahn, Philip, Rahimi, Homaira, Robinson, Angela Byun, Vehe, Richard K, Weiss, Jennifer E, Spencer, Charles, Juvenile Dermatomyositis Research Committee of the Childhood Arthritis and Rheumatology Research Alliance Show More Hide
Publisher(s):
The Journal of Rheumatology
Tags:
Medicine, Immunology and Microbiology
article description
Juvenile dermatomyositis (JDM) is the most common form of idiopathic inflammatory myopathy in children. While outcomes are generally thought to be good, persistence of skin rash is a common problem. The goal of this study was to describe the development of clinical treatment plans (CTP) for children with JDM characterized by persistent skin rash despite complete resolution of muscle involvement.

This article has 0 Wikipedia mention.